These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 25459581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S, Oppenheimer J.
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract] [Full Text] [Related]

  • 3. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 4. The potential of biologics for the treatment of asthma.
    Pelaia G, Vatrella A, Maselli R.
    Nat Rev Drug Discov; 2012 Dec; 11(12):958-72. PubMed ID: 23197041
    [Abstract] [Full Text] [Related]

  • 5. How do we interpret the data supporting the use of omalizumab for severe asthma?
    Lavietes MH.
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):335-6. PubMed ID: 25256024
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE, Figliomeni M, Spector S.
    Allergy Asthma Proc; 2012 Oct; 33(5):377-85. PubMed ID: 23026179
    [Abstract] [Full Text] [Related]

  • 8. The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.
    Yalcin AD, Bisgin A.
    Med Sci Monit; 2012 Aug; 18(8):LE9-10. PubMed ID: 22847211
    [No Abstract] [Full Text] [Related]

  • 9. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [Abstract] [Full Text] [Related]

  • 10. Summaries for patients. Omalizumab therapy for patients with severe asthma.
    Ann Intern Med; 2011 May 03; 154(9):I28. PubMed ID: 21536934
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Katsaounou P, Buhl R, Brusselle G, Pfister P, Martínez R, Wahn U, Bousquet J.
    Respir Med; 2019 Apr 03; 150():51-62. PubMed ID: 30961951
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ, Singh H, Diaz J, Peters JI.
    Ann Allergy Asthma Immunol; 2013 Jun 03; 110(6):457-61. PubMed ID: 23706716
    [Abstract] [Full Text] [Related]

  • 15. Omalizumab for asthma: indications, off-label uses and future directions.
    Ben-Shoshan M.
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov 03; 4(3):183-92. PubMed ID: 20807194
    [Abstract] [Full Text] [Related]

  • 16. [Oral steroids downgraded, biologics upgraded].
    Einecke D.
    MMW Fortschr Med; 2016 May 25; 158(10):86. PubMed ID: 27221447
    [No Abstract] [Full Text] [Related]

  • 17. [The add-on effect of omalizumab on patients with uncontrolled bronchial asthma].
    Minami Y, Endo S, Okumur S, Sasaki T, Yamamoto Y, Ogasa T, Osanai S, Ohsaki Y.
    Nihon Kokyuki Gakkai Zasshi; 2011 Nov 25; 49(11):793-9. PubMed ID: 22171481
    [Abstract] [Full Text] [Related]

  • 18. Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma.
    Sullivan PW, Campbell JD, Ghushchyan VH, Globe G.
    Ann Allergy Asthma Immunol; 2015 Jun 25; 114(6):462-9. PubMed ID: 25890451
    [Abstract] [Full Text] [Related]

  • 19. [Asthma therapy in transition. "For the physician it becomes ever more complicated" (interview by Dr. Elke Oberhofer)].
    Gillissen A, Oberhofer E.
    MMW Fortschr Med; 2014 Jun 12; 156(11):31. PubMed ID: 25022087
    [No Abstract] [Full Text] [Related]

  • 20. [Programs for continuing medical education: A session; 7. Current topics of asthma treatment--anti-IgE therapy].
    Adachi M, Tanaka A.
    Nihon Naika Gakkai Zasshi; 2012 Mar 10; 101(3):689-93. PubMed ID: 22620037
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.